Solicitation #: RFP-NIAID-DMID-75N93020R00004
“This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations.”
“Research supported by the NIAID, NIH, DHHS, strives to understand, treat, and ultimately prevent the myriad of infectious, immunologic, and allergic diseases that threaten millions of human lives. The DMID supports extramural research to study, control, and prevent diseases caused by all infectious agents. This includes basic, clinical, and applied research to develop and evaluate therapeutics, vaccines and diagnostics that are funded through a variety of research grants and contracts.
The evaluation of new and improved vaccine, diagnostics and therapeutic candidates in clinical trials and clinical studies is an essential element of the efforts of the NIAID. The Vaccine and Treatment Evaluation Units (VTEU), supported by the NIAID since the 1960’s, have designed and conducted a broad range of clinical studies and clinical trials of bacterial, viral and parasitic vaccines, therapeutics, and other biologics and drugs as preventive and therapeutic measures against infectious diseases in people of all ages and risk categories.”
“The contract(s) to be awarded under a Request for Proposal (RFP) for the requirements stated herein will provide central lab services to support clinical studies conducted at the VTEUs. The NIAID anticipates awarding multiple Indefinite Delivery Indefinite Quantity (IDIQ) contracts to fulfill the technical requirements of DMID. However, the NIAID reserves the right to award a single award IDIQ.”
Due date: 23 January 2020, 3:00 p.m. EST